# Elicio Therapeutics, Inc.: Form 8-K, filed Aug 12, 2024

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2024-08-12
- Accepted by EDGAR: Aug 12, 2024, 16:24 ET
- Period: 2024-08-12
- Accession: 0001140361-24-036848
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000114036124036848/ef20033947_8k.htm

Filed Aug 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-036848. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.